Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10537560
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10526346
Histone deacetylase inhibitors
granted -
US 10519153
Fused imidazo-piperidine JAK inhibitors
granted -
US 10519133
Vinyl compounds as FGFR and VEGFR inhibitors
granted -
US 10512673
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
granted -
US 10508106
Bicyclic BET bromodomain inhibitors and uses thereof
granted -
US 10508122
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
granted -
US 10501444
Inhibitors of influenza virus replication, application methods and uses thereof
granted -
US 10500194
Covalent small molecule DCN1 inhibitors and therapeutic methods using the same
granted -
US 10501439
DNA-PK inhibitors
granted -
US 10494364
Cathepsin K inhibitors and application thereof
granted -
US 10485803
Pyrimidine compounds as JAK kinase inhibitors
granted -
US 10485800
Mixed lineage kinase inhibitors for HIV/AIDS therapies
granted -
US 10479786
Protein kinase inhibitors
granted -
US 10478430
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted -
US 10478435
Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
granted -
US 10479784
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted -
US 10471061
Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
granted -
US 10471051
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10471055
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 10472387
Inhibitors of glucocorticoid receptor
granted -
US 2019337950
BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS
granted -
US 10463652
Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
granted -
US 10463663
Pyridazinone compounds and their use as DAAO inhibitors
granted